Vote Scores
Filings read through

INmune Bio Inc.: how funds voted at the meeting of 10 Jun 2025

Ticker
INMB
Meeting
Season
year to 30 June 2025
Filers reporting
128
Ballot items
5

128 filers on Form N-PX reported votes at the INmune Bio Inc. meeting of 10 Jun 2025. The records fall into 5 ballot items. The page lists them in ballot order: items of the company first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting.

This meeting is in the year to 30 June 2025. The latest season on file is the year to 30 June 2026. The page of INmune Bio Inc. has the latest meeting.

If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.

The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .

The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.

The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.

The page gives records. It gives no investment advice and no advice on how to vote.

Season on this page: year to 30 June 2025. Filings read through . How the figures are made

The ballot

ForAgainstAbstain, withhold or otherAmber tick: the part cast against management

  1. Item 1: Director elections

    5 nominees. 45.1% of the reported votes are for. 36 filers withheld from or voted against at least one nominee.

    355 vote records from 40 filers. 19 of the 40 filers that marked the item voted against management.

    • Positions of 23 fund families
    • For 9
    • Abstain or withhold 14
    • Against management 14
  2. Item 2: Advisory vote on executive pay (say-on-pay)

    170 vote records from 126 filers. 16 of the 117 filers that marked the item voted against management. 9 filers gave no management mark.

    • Positions of 32 fund families
    • For 26
    • Against 6
    • Against management 6
  3. Item 3: Frequency of the say-on-pay vote

    One year: 108 filers. Three years: 7 filers. For: 2 filers. Against: 1 filer.

    172 vote records from 127 filers. 109 of the 118 filers that marked the item voted against management. 9 filers gave no management mark.

    • Positions of 32 fund families
    • Split or no vote 32
    • Against management 31
  4. Item 4: Audit-related items (auditor ratification)

    71 vote records from 40 filers. 0 of the 40 filers that marked the item voted against management.

    • Positions of 23 fund families
    • For 23
  5. Item 5: COMPENSATION: management items

    The company's items in this category are shown together, because filers word and number them differently.

    72 vote records from 41 filers. 28 of the 41 filers that marked the item voted against management.

    • Positions of 23 fund families
    • For 6
    • Against 17
    • Against management 17

Positions of the fund families

A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.

KeyForAgainstAbstain or withholdSplit or no voteAgainst management

Fund families at INmune Bio Inc., meeting of 10 Jun 2025Families in name order. "Abstain" includes withhold. "Split" includes no vote. "No report" means that no filer of the family listed the item.
Fund family2. Say-on-pay3. Pay-vote frequency4. Auditor
AllianceBernsteinAgainst, against managementSplit, against managementNo report
American CenturyAgainst, against managementSplit, against managementFor
BairdForSplit, against managementNo report
BlackRock and iSharesForSplit, against managementFor
BNY MellonForSplit, against managementNo report
Charles SchwabForSplit, against managementFor
Columbia ThreadneedleForSplit, against managementFor
DimensionalForSplitFor
DWSForSplit, against managementFor
EquitableAgainst, against managementSplit, against managementFor
FidelityForSplit, against managementFor
First TrustAgainst, against managementSplit, against managementNo report
Global XForSplit, against managementFor
Goldman SachsForSplit, against managementFor
Guggenheim and RydexForSplit, against managementFor
InvescoAgainst, against managementSplit, against managementNo report
J.P. MorganForSplit, against managementNo report
John Hancock and ManulifeForSplit, against managementFor
Lincoln FinancialForSplit, against managementFor
Morgan Stanley, Eaton Vance and CalvertAgainst, against managementSplit, against managementFor
NationwideForSplit, against managementFor
Neuberger BermanForSplit, against managementNo report
Northern Trust and FlexSharesForSplit, against managementFor
Nuveen and TIAAForSplit, against managementFor
Pacific Life fundsForSplit, against managementFor
PGIM and PrudentialForSplit, against managementNo report
PrincipalForSplit, against managementNo report
ProShares and ProFundsForSplit, against managementFor
State Street and SPDRForSplit, against managementFor
T. Rowe PriceForSplit, against managementFor
VanguardForSplit, against managementFor
VoyaForSplit, against managementFor

Questions

How many filers reported votes at the INmune Bio Inc. meeting?
128 Form N-PX filers reported votes at the meeting of 10 Jun 2025. On say-on-pay, 16 of 117 filers that marked the item voted against management (13.7%).
Is this the result of the meeting?
No. The page counts the filers that report on Form N-PX, and the shares they reported. INmune Bio Inc. reports the result of a vote on Form 8-K.
Why does the page show counts only for director elections?
A director record names the nominee. This site has no page and no row about a person. For director elections it keeps the number of nominees and the split of votes.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list INmune Bio Inc. with a meeting date within three days of 10 Jun 2025. A proposal title is the most common wording among filers. Where a wording can name a person, the SEC category is shown. The filers wrote the filings. Filings read through .